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Proteomemodifications downstreamofmonogenic or polygenic disorders have the potential to uncover novelmolecularmechanisms partici-
pating in pathogenesis and/or extragenicmodification of phenotypic expression.We tested this idea by determining the proteome sensitive to
genetic defects in a locus encoding dysbindin, a protein required for synapse biology and implicated in schizophrenia risk.We applied quanti-
tative mass spectrometry to identify proteins expressed in neuronal cells the abundance of which was altered after downregulation of the
schizophrenia susceptibility factor dysbindin (Bloc1s8) or two other dysbindin-interacting polypeptides, which assemble into the octameric
biogenesisof lysosome-relatedorganelles complex1 (BLOC-1).We found491proteins sensitive todysbindinandBLOC-1 lossof function.Gene
ontology of these 491 proteins singled out the actin cytoskeleton and the actin polymerization factor, the Arp2/3 complex, as top statistical
molecular pathways containedwithin the BLOC-1-sensitive proteome. Subunits of the Arp2/3 complex were downregulated by BLOC-1 loss of
function, thus affecting actin dynamics in early endosomes of BLOC-1-deficient cells. Furthermore, we demonstrated that Arp2/3, dysbindin,
and subunits of the BLOC-1 complex biochemically and genetically interact, modulating Drosophila melanogaster synapse morphology and
homeostatic synaptic plasticity. Our results indicate that ontologically prioritized proteomics identifies novel pathways that modify synaptic
phenotypes associatedwith neurodevelopmental disorder gene defects.
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Introduction
Genomes of individuals affected by polygenic disorders of high
hereditability have offered a fertile ground for harvesting risk
genes converging into putative disorder mechanisms. Such is the
case of schizophrenia, a complex polygenic disorder in which
high-confidence genetic risk factors have recently converged into
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Significance Statement
Themechanisms associated with schizophrenia aremostly unknown despite the increasing number of genetic loci identified that
increase disease risk. We present an experimental strategy that impartially and comprehensively interrogates the proteome of
neurons to identify effects of genetic mutations in a schizophrenia risk factor, dysbindin. We find that the expression of the actin
polymerization complexArp2/3 is reduced in dysbindin-deficient cells, thus affecting actin-dependent phenotypes in two cellular
compartments where dysbindin resides, endosomes and presynapses. Our studies indicate that a central cellular structure af-
fectedby schizophrenia susceptibility loci is the actin cytoskeleton, anorganelle necessary for synaptic function in thepresynaptic
and postsynaptic compartment.
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discrete cellular and molecular pathways (Gilman et al., 2012;
Fromer et al., 2014; Purcell et al., 2014). These ontologically in-
formedpathways often implicate synapse function as a pathogen-
esismechanism. Individual genetic risk loci are likely to influence
the expression of multiple proteins encoded by genes other than
the affected locus (Picotti et al., 2013;Wu et al., 2013; Albert et al.,
2014). These proteins downstream of a single risk allele could
map within a protein complex, cellular pathway, or organelle.
This suggests, that in in addition to genomes, proteomes could
eitherwiden the spectrumofmechanisms downstreamof defined
schizophrenia genetic risk factors and/or increase the confidence
in putative disorder pathways solely defined by genomic data
(Mullin et al., 2013). We hypothesized that proteome modifica-
tions downstream of a single gene defect should reveal novel and
overlapping mechanisms with pathways defined by genomic
studies in schizophrenia patients. We reasoned that this hypoth-
esis could be best examined by studying the proteome sensitive to
a gene encoding a subunit of a protein complex that is required
for synapse biology and implicated in schizophrenia risk.
We tested this hypothesis using monogenic defects affecting
subunits of biogenesis of lysosome-related organelles complex 1
(BLOC-1) (Ghiani and Dell’Angelica, 2011; Gokhale et al., 2012;
Mullin et al., 2013). The BLOC-1 complex is an obligate octamer
constituted by blos1, 2, 3 (Bloc1s1–3), cappuccino (Bloc1s4),
muted (Bloc1s5), pallidin (Bloc1s6), snapin (Bloc1s7), and dys-
bindin (Bloc1s8) (Ghiani and Dell’Angelica, 2011; Gokhale et al.,
2012; Mullin et al., 2013). Importantly, the stability of the
BLOC-1 complex strictly requires the integrity of all of its sub-
units as determined from genetic defects in one subunit, which
decrease the expression of transcripts and polypeptides encoding
other subunits within the BLOC-1 complex (Huang et al., 1999;
Zhang et al., 2002; Ciciotte et al., 2003; Li et al., 2003; Gwynn et
al., 2004; Starcevic and Dell’Angelica, 2004; Wei, 2006; Yang et
al., 2012; Larimore et al., 2014).
Dysbindin and BLOC-1 subunits localized to the synapse and
are required for diverse presynaptic and postsynaptic mecha-
nisms ranging from synaptic vesicle recycling to homeostatic syn-
aptic plasticity (Dickman and Davis, 2009; Newell-Litwa et al.,
2009; Newell-Litwa et al., 2010; Larimore et al., 2011; Dickman et
al., 2012; Di Giovanni and Sheng, 2015; Gokhale et al., 2015b;
Mullin et al., 2015). Predictably,Bloc1s8 deficiency alleles, such as
the sandy mouse (Bloc1s8 sdy/sdy) or the Drosophila dysb1 allele,
cause behavioral and cognitive phenotypes, some resembling
schizophrenia phenotypes (Cox et al., 2009; Jentsch et al., 2009;
Shao et al., 2011; Wolf et al., 2011; Papaleo et al., 2012; Mullin et
al., 2015). A powerful argument for a role of the BLOC-1 complex
in schizophrenia mechanisms is the observation that dysbindin
expression is selectively reduced in the majority of schizophrenia
brains regardless of the DTNBP1 allele encoding dysbindin in
these patients (Talbot et al., 2004; Tang et al., 2009; Talbot et al.,
2011). Polymorphisms in the gene encoding dysbindin were ini-
tially reported as risk factors for schizophrenia, yet this assertion
has been challenged by recent genomic meta-analyses (Straub et
al., 2002; Gornick et al., 2005; Talbot et al., 2009; Fatjo´-Vilas et al.,
2011; Mullin et al., 2011; Farrell et al., 2015). This evidence indi-
cates that risk loci outside of the DTNBP1 locus regulate the
expression of dysbindin in individuals affected by schizophrenia
and suggests that altered dysbindin protein expression is a better
disorder risk predictor.
Here, we used quantitativemass spectrometry to identify pro-
teins with expression that is modified by diminishing the expres-
sion of one of three BLOC-1 subunits, muted (Bloc1s5), pallidin
(Bloc1s6), and dysbindin (Bloc1s8), in neuronal cells. We de-
fined 491 proteins sensitive to dysbindin and BLOC-1 loss of
function, the BLOC-1-sensitive proteome, which we prioritized
statistically by gene ontology (GO) analyses. Unbiased GO
brought into focus the actin polymerization factor, the Arp2/3
complex. Conditional genetic disruption of the Arp2/3 complex
causes schizophrenia endophenotypes in mouse (Kim et al.,
2015). Furthermore, Arp2/3 subunit transcripts are decreased in
the prefrontal cortex of schizophrenia patients, revealing the rel-
evance of the Arp2/3 complex for the pathogenesis of schizophre-
nia (Datta et al., 2016). We demonstrated that Arp2/3 interacts
genetically with dysbindin and the BLOC-1 complex subunits
Blos1 and pallidin to modulate Drosophila neuromuscular syn-
apse morphology and homeostatic synaptic plasticity, an adap-
tive response of the presynaptic compartment (Dickman and
Davis, 2009; Dickman et al., 2012; Gokhale et al., 2015b). As
predicted, the proteome sensitive to BLOC-1 deficiencies en-
riched gene products implicated in psychosis and schizophrenia
risk and GO categories previously associated with schizophrenia
gene candidates identified in population genomic studies. Our
results indicate that ontologically prioritized proteomics identify
novel synaptic mechanisms downstream of individual neurode-
velopmental disorder risk factors. We propose that protein ex-
pression traits emanating from disorder risk alleles expand and
strengthen mechanistic insight gained from population genomic
studies.
Materials andMethods
Animals. We used C57BL/6 and Bloc1s8 sdy/sdy mice (Mus musculus) de-
scribed previously. Animals of both sexes were used (Larimore et al.,
2014). Animal procedures and studies were approved by the Emory Uni-
versity Institutional Animal Care and Use Committee.
Antibodies. Antibodies against rabbit ArpC2 and ArpC5 (15058-1-AP
and 16717-1-AP, 1:1000 blot dilution; ProteinTech Group), rabbit ArpC2
used for immunoprecipitation (07-227, 1 g; Millipore), rabbit plexin A2
(6896, 1:1000 blot dilution; Cell Signaling Technology), rabbit dysbindin
(HPA029616, 1:125 blot dilution; Sigma-Aldrich), rabbit ataxin 2 (A301-
118A, 1:2000 blot dilution; Bethyl), mouse VAMP7 (1:750 blot dilution; a
gift from Dr. A.A. Peden, Sheffield University, UK), mouse pallidin clone
2G6 (1:500 blot dilution; a gift fromDr. EstebanDell’Angelica,University of
California–LosAngeles), rabbitFAM21(MC2188,1:2000blotdilution; agift
fromDr. Daniel Billadeau, Mayo Cilinic, Rochester, MN), rabbit strumpel-
lin (SC87442, 1:1000 blot dilution; Santa Cruz Biotechnology), mouse actin
clone AC-15 (A5451, 1:500 blot dilution; Sigma-Aldrich) mouse monoclo-
nal SV2(Clone10H,1:500blotdilution;Developmental StudiesHybridoma
Bank),mousemonoclonalHSP90 (610418, blot dilution 1:1000; BDBiosci-
ences), and mouse monoclonal FLAG (M2 clone, F-3165, 1 g used for
immunoprecipitation, blot dilution 1:1000; Sigma-Aldrich).
Cell culture, homogenate preparation, and brain fractionation.
HEK293T and SH-SY5Y cells (American Type Culture Collection),
WASHflox/flox, and WASH-null mouse embryonic fibroblasts were cul-
tured in DMEM supplemented with 10% fetal bovine serum (FBS) and
100 g/ml penicillin and streptomycin (Hyclone) at 37°C in 10% CO2.
Bloc1s5mu /mu, Bloc1s6pa / pa, and rescued melanocytes were a gift from
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Dr.MichaelMarks (Department of Pathology and LaboratoryMedicine,
University of Pennsylvania, Philadelphia; Setty et al., 2007; Setty et al.,
2008).WASHflox/flox andWASH-nullmouse embryonic fibroblasts were
gifts from Dr. Daniel Billadeau (Department Medical Oncology, College
of Medicine, Mayo Clinic, Rochester, MN; Gomez et al., 2012). MNT-1
cells were a generous gift fromDr. Vincent Hearing and were cultured as
described previously (Kushimoto et al., 2001). shRNA-mediated Bloc1s5
muted and Bloc1s6 pallidin knockdowns were generated as described
previously (Gokhale et al., 2015b). Briefly, shRNA in a pLKO.1 vector for
lentiviral infection was obtained fromOpen Biosystems (Pallidin, Clone
ID: TRCN0000122781; Muted, Clone ID: TRCN0000128812). Control
shRNA in pLKO.1 was obtained from Addgene (vector 1864). For
shRNA-mediated dysbindin knockdowns, shRNA in a psiHIV-U6 vector
for lentiviral infection was obtained fromGeneCopoeia (Dysbindin, cat-
alog #HSH020444-1HIVU6). Control shRNA in a psiHIV-U6 vector was
also obtained from GeneCopoeia (control, catalog #CSCHCTR001-
HIVU6). SH-SY5Y cells were treated with lentiviral particles for 7 d to
obtain efficient knockdown. After day 3 of lentiviral infection, cells were
maintained in DMEM supplemented with 10% FBS and selected with
puromycin (2g/ml; Invitrogen). Detergent-soluble cellular lysates were
prepared as described previously (Gokhale et al., 2015b). Briefly, cells
were scraped from the dish and cell homogenates were centrifuged at
16,100  g for 10 min. The clarified supernatant was recovered and
measured for total protein content. Samples were resolved by SDS-PAGE
and contents were analyzed by immunoblot as described previously
(Gokhale et al., 2015b).
Adult brains (postnatal day 50, P50) of C57BL/6 and Bloc1s8 sdy/sdy
mice were fractionated according to the Nagy and Delgado-Escueta
(1984) method except that we used the P2 fractions as a crude synapto-
some preparation for immunoblot analysis. A total of six animals were
fractionated in three independent experiments.
Stable isotope labeling by amino acids in cell culture (SILAC) quantita-
tive mass spectrometry. SH-SY5Y cells were labeled using the protocol
described previously by us (Perez-Cornejo et al., 2012; Ryder et al., 2013;
Gokhale et al., 2015b). Briefly, cells were grown in DMEM with either
“light” unlabeled arginine and lysine amino acids (R0K0) or “heavy”
13C- and 15N-labeled arginine and 13C- and 15N-labeled lysine amino
acids (R10K8) supplementedwith 10%FBS and 100g/ml penicillin and
streptomycin and, in some cases, 2 g/ml puromycin. Cells were grown
for a minimum of seven passages, ensuring incorporation of the amino
acids in the cellular protein pool at98%. All reagents for SILAC label-
ingwere obtained fromDundee Cell Products. Cell lysates were prepared
as described below and analyzed by mass spectrometry, as described
previously (Perez-Cornejo et al., 2012; Ryder et al., 2013; Gokhale et al.,
2015b). SILACmass spectrometry services were contracted fromMSBio-
works http://www.msbioworks.com/
Tandem mass tagging (TMT) quantitative mass spectrometry. Whole
brain tissue from C57BL/6 and Bloc1s8 sdy/sdy P1 mice was flash frozen in
liquid nitrogen and stored at80°C. Tissue was homogenized in 500 l
of urea lysis buffer (8 M urea, 100 mM NaH2PO4, pH 8.5), including 5 l
of (100 stock) HALT protease and phosphatase inhibitor mixture
(Pierce). Homogenization was performed using a Bullet Blender (Next
Advance) according to the manufacturer’s protocols. Briefly, each tissue
piece was added to urea lysis buffer in a 1.5ml Rino tube (Next Advance)
harboring 750 mg stainless steel beads (0.9–2 mm in diameter) and
blended twice for 5 min intervals in the cold room (4°C). Protein super-
natants were transferred to 1.5 ml Eppendorf tubes and sonicated (Sonic
Dismembrator; Fisher Scientific) 3 times for 5 s with 15 s intervals of rest
at 30% amplitude to disrupt nucleic acids and subsequently vortexed.
Protein concentrationwas determined by the bicinchoninic acidmethod
and sampleswere frozen in aliquots at80°C. Protein homogenates (100
g) were diluted with 50 mM triethylammonium bicarbonate (TEAB) to
a final concentration of 2 M urea and then treated with 1 mM dithio-
threitol at 25°C for 30 min, followed by 5 mM iodoacetimide at 25°C for
30min in the dark. Protein was digested with 1:100 (w/w) lysyl endopep-
tidase (Wako) at 25°C for 2 h and further digested overnight with 1:50
(w/w) trypsin (Promega) at 25°C. Resulting peptides were desalted with
a Sep-Pak C18 column (Waters). An aliquot equivalent to 20 g of total
protein was taken out of each sample and combined to obtain a global
internal standard (GIS) use later for TMT labeling (the total was split into
eight aliquots equivalent to 70g of total protein). An additional aliquot
of 10 g was taken from each sample to test the digestion efficiency and
overall peptide composition. Samples were dried down using a Savant
SpeedVac (ThermoFisher Scientific).
TMT labeling was performed according to the manufacturer’s proto-
col. Briefly, the reagents were allowed to equilibrate to room tempera-
ture. Dried peptide samples (70 g each) were resuspended in 100 l of
100 mM TEAB buffer (supplied with the kit). Anhydrous acetonitrile (41
l) was added to each labeling reagent tube and the peptide solutions
were transferred into their respective channel tubes. The reaction was
incubated for 1 h and quenched for 15 min afterward with 8 l of 5%
hydroxylamine. All samples were combined and dried down. Peptides
were resuspended in 100 l of 90% acetonitrile and 0.01% acetic acid.
The entire sample was loaded onto an offline electrostatic repulsion–
hydrophilic interaction chromatography fractionation HPLC system
and 40 fractions were collected over a time of 40 min. The fractions were
combined into 20 and dried down. Dried peptide fractions were resus-
pended in 30 l of peptide loading buffer (0.1% formic acid, 0.03%
trifluoroacetic acid, 1% acetonitrile). Peptide mixtures (2 l) were sep-
arated on a self-packed C18 (1.9 m Dr. Maisch, Germany) fused silica
column (25 cm 75 M internal diameter; New Objective) by a Dionex
Ultimate 3000 RSLCNano and monitored on a Fusion mass spectrome-
ter (ThermoFisher Scientific). Elution was performed over a 140 min
gradient at a rate of 300 nl/min with buffer B ranging from 3% to 80%
(buffer A: 0.1% formic acid in water, buffer B: 0.1% formic in acetoni-
trile). The mass spectrometer cycle was programmed to collect at the top
speed for 3 s cycles in synchronous precursor selection mode. The MS
scans (380-1500 m/z range, 200,000 AGC, 50 ms maximum ion time)
were collected at a resolution of 120,000 atm/z 200 in profile mode. CID
MS/MS spectra (1.5 m/z isolation width, 35% collision energy, 10,000
AGC target, 50 ms maximum ion time) were detected in the ion trap.
HCD MS/MS/MS spectra (2 m/z isolation width, 65% collision energy,
100,000 AGC target, 120 ms maximum ion time) of the top 10 MS/MS
product ions were collected in the Orbitrap at a resolution of 60000.
Dynamic exclusionwas set to exclude previous sequenced precursor ions
for 30 s within a 10 ppm window. Precursor ions with 1 and 8 or
higher charge states were excluded from sequencing.
MS/MS spectra were searched against a Uniprot curated mouse data-
base (downloaded on 03/06/2015 with 53289 target sequences) with Pro-
teome Discoverer 2.1 (ThermoFisher Scientific). Methionine oxidation
(15.9949 Da), asparagine, and glutamine deamidation (0.9840 Da)
and protein N-terminal acetylation (42.0106 Da) were variable modi-
fications (up to 3 allowed per peptide); static modifications included
cysteine carbamidomethyl (57.0215 Da), peptide n terminus TMT
(229.16293 Da), and lysine TMT (229.16293 Da). Only fully tryptic
peptides were considered with up to two miscleavages in the database
search. A precursor mass tolerance of 	20 ppm and a fragment mass
tolerance of 0.6 Da were applied. Spectra matches were filtered by Per-
colator to a peptide-spectrummatches false discovery rate of1%. Only
razor and unique peptideswere used for abundance calculations. Ratio of
sample over the GIS of normalized channel abundances were used for
comparison across all samples.
Microscopy. HEK293T cells stably expressing Signal-Sequence FLAG
tagged -2 adrenergic receptors (SSF-B2AR) were used. Cells were
treated with scrambled or Bloc1s6 shRNAs, selected for 7 d in puromy-
cin, and transiently transfectedwith LifeAct-GFP, LifeAct-RFP, or Actin-
GFP. Cells were imaged 10min after the addition of 10M isoproterenol
to induce receptor internalization. Functional endosomes were labeled
using anti-flag M1 antibody conjugated to Alexa Fluor-647 dye. Cells
were grown on coverslips andmaintained in 10%FBS (Invitrogen) high-
glucose DMEM (HyClone) and imaged in Opti-MEM (Invitrogen) with
10% FBS and buffered to pH 7.4 with 40 mM HEPES. Live-cell confocal
images were collected on an Andor Revolution XD SpinningDisk system
with a Nikon Eclipse Ti inverted microscope. Objective used for capture
was a 100 1.49 numerical aperture TIRF objective from Nikon. Both
microscope and objectives were housed in a temperature-controlled case
maintained at 37°C. Light sources were 488 nm and 561 and 647 nm
solid-state lasers and images were captured on an iXON 897 EM-CCD
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Camera using Andor iQ. Image analysis was performed on raw images in
ImageJ. Images were not modified in anyway other than color and
brightness/contrast assignment for multichannel images.
Drosophila stocks, rearing, genetics, electrophysiology, and microscopy. All
fly stocks (Drosophila melanogaster) were reared andmaintained at 25°C on
two food formulations. All fly experiments were performed on female ani-
mals. The food formulation was prepared with 2.7 l of water, 96 g of yeast,
240 g of cornmeal, 18 g of agar, 240 g of molasses, 18 ml of propionic acid,
48 g of tegosep, and 48ml of ethanol (Mullin et al., 2015).DD foodwas used
as described previously by Dickman et al. (Dickman andDavis, 2009; Dick-
man et al., 2012) and made as follows: 2.7 l of water, 33 g of yeast, 163 g of
cornmeal, 16 g of agar, 200ml of corn syrup, 4.3 g of tegosept, and 34ml of
ethanol. For crosses, standard secondand third chromosomebalancerswere
used. w1118 and other fly strains such as balancer chromosome containing
dysb 1 and blos1 ex65 were described previously (Mullin et al., 2015).
Arpc1Q25st/ and Arpc1Q25sd/ were a gift from Dr. Lynn Cooley of Yale
University (Hudson and Cooley, 2002). Two additional stocks ofw1118 an-
imalswereobtained fromtheBloomingtonStockCenter (#5905and#3605).
Additional fly strains used in this study included w1118,ppk-EGFP; Sp/CyO
(Grueber et al., 2003); y,w,hsFLP; Arpc1Q25sd,FRT40A (Bloomington stock
#9137); and w,GAL45–40,UAS-Venus.pm,SOP-FLP42;tubP-GAL80,FRT40A
(Shimono et al., 2014). Live confocal imaging was performed as described
previously (Iyer et al., 2013b). Briefly, live third-instar larvae were placed on
amicroscope slide, immersed in1:5 (v/v)diethyl ether tohalocarbonoil, and
covered with a 22 50 mm glass coverslip. Neurons expressing GFP were
visualizedonaZeiss LSM780 confocalmicroscope. Imageswere collected as
z-stacks using a 20 dry objective at a step-size of 2.0mand 1024 1024
resolution.MARCManalyseswere performed essentially as describedprevi-
ously (Sulkowski et al., 2011). Briefly, for generating dendritic arborization
(DA) neuron MARCM clones, Arpc1Q25sd,FRT40A flies were crossed to
w,GAL45–40,UAS-Venus.pm,SOP-FLP42;tubP-GAL80,FRT40A flies (DGRC
stock #109-947). Third instar larvae with GFP-labeled neurons were sub-
jected to live-cell confocal microscopy. Larval dissections, immunohisto-
chemistry, and confocalmicroscopywere conducted asdescribedpreviously
(Franciscovich et al., 2008). Wandering third-instar female larvae were dis-
sected in normal HL3, fixed in 4% paraformaldehyde for 1 h, and stained
withHRP–FITC for 2 h at room temperature (1:500). An inverted 510 Zeiss
LSMmicroscopewasused for confocal imagingof synapses atmuscle 6/7 on
either the second or third segment. Homeostatic synaptic plasticity studies
were performed as described previously (Dickman and Davis, 2009; Dick-
man et al., 2012; Gokhale et al., 2015b).
Quantitative analyses of neuronal reconstructions were performed as
described previously (Iyer et al., 2013a) with some modifications.
Maximum-intensity projections of the z-stacks were exported as jpeg or
tiff files using Zeiss Zen-blue software. Exported images were curated
manually to eliminate nonspecific autofluorescent spots such as the lar-
val denticle belts using a custom-designed program, Flyboys (Cox Labo-
ratory). The raw pixel intensity for each image was globally thresholded
and converted to a binary file format in Photoshop (Adobe). Background
image noise was filtered out using the Analyze Particles plugin http://
rsbweb.nih.gov/ij/docs/menus/analyze.html#ap in ImageJ [size (pix-
els2)50 m, circularity0.35]. Next, images were skeletonized (con-
version to 1-pixel-wide “skeletons”) using the Skeletonize3D plugin
http://fiji.sc/wiki/index.php/Skeletonize3D in Fiji/ImageJ followed by
use of the Analyze Skeleton Fiji/ImageJ plugin http://fiji.sc/wiki/index.
php/AnalyzeSkeleton for the output of quantitative neurometric mea-
sures of dendritic morphology. Quantitative neurometric information
including total dendritic length and total dendritic branches were ex-
tracted and compiled using custom Python algorithms and imported
into Microsoft Excel. For Strahler analysis, a Fiji plugin http://fiji.sc/
Strahler_Analysis was used to analyze the skeletonized images by itera-
tively pruning terminal branches and determining the branch number in
each iteration.
The precise deletion of the pallidin locus was generated using FLP-
mediated recombination between pairs of transposon-based Flp recombi-
nase target (FRT) sites, as described in the DrosDel Collection (Parks et al.,
2004). Specifically, two transposons flanking the pallidin locus,
PBac{WH}f05716andPBac{WH}f05753,wereobtained fromtheBlooming-
tonDrosophila Stock Center. Each contained FRT sites in the correct orien-
tation to permit a precise deletion. After FLP-mediated recombination and
excision of the remaining hybrid transposon, we confirmed the deletion by
PCRusing the following primers: forward primer 5
-TCCCGAGCTGCAT-
GTTGAAT; reverse primer 5
-GTTTGAAACTTAGCTGCGCGA. This re-
vealed that bases 11,689,5565 to 11,691,527 on chromosome 3L were
deleted.
Bioinformatics. Gene list to disease associations were performed with
the GDA algorithm http://gda.cs.tufts.edu/; Park et al., 2014 and gene
expression analysis was performed with the CSEA tool http://genetics.
wustl.edu/jdlab/csea-tool-2/; Dougherty et al., 2010. Three algorithms
were used to perform GO analysis. The BLOC-1-sensitive proteome was
analyzed by GeneTerm Linker http://gtlinker.cnb.csic.es/gtset/index;
Fontanillo et al., 2011, ENRICH http://amp.pharm.mssm.edu/En-
richr/; Chen et al., 2013, and Database Annotation, Visualization and
IntegratedDiscovery (DAVID, https://david.ncifcrf.gov;HuangDa et al.,
2009). Cytoscape with Enrichment Map plugin for visualizing DAVID
outputs was used to depict integrations between GO terms associated
with the BLOC-1-sensitive proteome (Shannon et al., 2003;Merico et al.,
2010). Briefly, gene lists uploaded to DAVID were analyzed by setting
annotations based by species (Homo sapiens) in annotation databases
such as GOTERM_BP_FAT or GOTERM_CC_FAT, which would pro-
duce a functional annotation chart for molecular function and cellular
component, respectively (Huang Da et al., 2009). Parameters for these
functional annotation charts included p-value cutoff (0.01), a mini-
mum number of three genes for each GO term, fold enrichment, and
Bonferroni and/or Benjamini corrected statistical analysis to control for
false discovery (Huang Da et al., 2009). Charts were narrowed down to
simplify Cytoscape representations by eliminating broad GO terms.
Statistical analysis. Experimental conditions were compared using
Synergy Kaleida-Graph version 4.1.3 as specified in each figure.
Results
Identification of a Dysbindin-BLOC-1-sensitive proteome
Deficiencies in dysbindin and other BLOC-1 subunits generate
phenotypes inmultiple cellular systems, yet a comprehensive un-
derstanding of molecular mechanisms upstream or downstream
of each one of these phenotypes is still lacking. We sought to
answer this question in neuronal tissue because dysbindin is re-
quired for synapse function and plasticity and because dysbindin
expression is reduced in the majority of schizophrenia brains
(Talbot et al., 2004; Mullin et al., 2011; Talbot et al., 2011; Ghiani
andDell’Angelica, 2011).We hypothesized thatmolecularmech-
anisms sensitive to dysbindin-BLOC-1 complex deficiencies
should be represented as pathway-specific changes in protein ex-
pression, should enrich gene products implicated in schizophre-
nia risk, and should include gene products capable of modifying
the phenotypic expression of dysbindin-BLOC-1 mutant alleles.
We began testing this hypothesis and its predictions by quan-
titatively profiling protein expression in Bloc1s8 sdy/sdy mouse
brains and human SH-SY5Y neuroblastoma cells in which we
downregulated the expression of one BLOC-1 subunit (Fig. 1).
The quantitative proteome of mutant and wild-type P0 mouse
brains was determined using in vitro 10-plex tandem mass tag-
ging of brain homogenate peptides with isobaric tag reagents
(TMT; Thompson et al., 2003). We focused on P0 mouse brains
because the highest expression of dysbindin occurs during late
embryonic development and declines progressively after birth
(Ghiani et al., 2010). The quantitative proteome of control and
BLOC-1 downregulated neuroblastoma cells was determined by
in vivo SILAC (Fig. 1; Ong et al., 2002).
We simultaneously quantitated 5922 proteins from four wild-
type and fiveBloc1s8 sdy/sdymutantbrainsbyTMTand identified270
proteins with content that was modified significantly by the muta-
tion (Fig. 2A,A2). Of these proteins, 161 were upregulated and 109
were downregulated in Bloc1s8 sdy/sdy brains (Fig. 2A1,A2). Among
the proteins downregulated were just two known proteins with ex-
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pression that is reduced in BLOC-1 deficiencies, the BLOC-1 sub-
unit Bloc1s1 and Vamp7 (Fig. 2A2; Starcevic and Dell’Angelica,
2004; Salazar et al., 2006; Newell-Litwa et al., 2010). Therefore, the
identification of BLOC-1-sensitive proteins might have been com-
promised by the complexity of whole-brain proteomes. Therefore,
we complemented thewhole-brain proteome studieswith quantita-
tive SILACproteomeanalyses of SH-SY5Yneuroblastoma cells (Fig.
1). We reasoned that a homogeneous cell line would allow identifi-
cation of additional proteins inwhich a BLOC-1-dependent expres-
sion phenotypemight bemasked by different penetrance because of
age, multiplicity of cell types, and anatomical region in brains. Neu-
roblastoma cells were transducedwith lentiviruses expressing a con-
trol shRNA or hairpins against the BLOC-1 subunits Bloc1s5 or
Bloc1s6. The BLOC-1-targeting hairpins selectively and strongly
downregulated the expression of dysbindin (Bloc1s8) in neuroblas-
toma cells (see Fig. 5A). We performed five independent SILAC
experiments totaling 16,496 protein quantitations (Fig. 2B). SILAC
proteomics identified 221 proteins in which the content was selec-
tivelymodified by downregulation of the BLOC-1 subunits Bloc1s5
or Bloc1s6 (Fig. 2B). Upregulated and downregulated proteins were
evenlydistributed (Fig. 2B1,B2).We identified theBLOC-1 subunits
Bloc1s4 (CNO) and Bloc1s5 (MUTED), the SNARE VAMP7, the
copper transporter ATP7A, then-ethymaleimide-sensitive factor, as
well as other components of the vesicle fusion apparatus (STXBP1
and5) and annexinA2 (ANXA2).We reportedpreviously that these
molecules are downregulated in BLOC-1 deficiency and participate
in common mechanisms with BLOC-1,
thus validating our proteome (Newell-
Litwa et al., 2010; Gokhale et al., 2015a;
Gokhale et al., 2015b;Delevoye et al., 2016).
Weadditionally selectedAtaxin2andplexin
A2 for confirmation because they suggest
novel mechanisms intersecting with
BLOC-1, includingmRNAmetabolismand
semaphorin receptor activity (Suto et al.,
2007; Lim and Allada, 2013; Yokoshi et al.,
2014). Ataxin 2 (ATXN2) and plexin A2
(PLXNA2) were upregulated in the pro-
teome, a result that we confirmed in neuro-
blastoma cells in which BLOC-1 was
downregulated by distinct BLOC-1 subunit
shRNAs (Fig. 2B1 and see Fig. 5A–C, A1–
C1). Collectively, TMT and SILAC quanti-
tative mass spectrometry generated a
candidate list of 491 proteins sensitive to
dysbindin and BLOC-1 loss of function,
henceforth referred to as theBLOC-1-sensi-
tive proteome.
The BLOC-1-sensitive proteome sig-
nificantly enriched gene products impli-
cated in neurodevelopmental disorders
such as schizophrenia. This disorder
ranked among the three top hits accord-
ing to the GDA algorithm (Park et al.,
2014; Fig. 3A). This statistical association
of the BLOC-1-sensitive proteome with
schizophrenia was further strengthened
by its similarity to other gene sets associ-
ated with schizophrenia, which are en-
riched in gene products expressed in
human fetal brain development (Gul-
suner et al., 2013; Network and Pathway
Analysis Subgroup of Psychiatric Genom-
ics, 2015; Fig. 3B). Moreover, the BLOC-1-sensitive proteome
predicted a significant enrichment of gene products in develop-
ing hippocampus, amygdala, and thalamus (Fig. 3B). These brain
regions are themost compromised by volume reductions in adult
schizophrenia patients (van Erp et al., 2016; Okada et al., 2016).
These unbiased analyses indicate that the BLOC-1-sensitive pro-
teome enriches gene products and anatomical domains impli-
cated in neurodevelopmental disorders.
Ontological prioritization of BLOC-1 converging pathways
The overlap between the brain and the neuroblastoma BLOC-1-
sensitive proteomes was limited to just 12 proteins, suggesting
that convergence between these proteomes could occur at a
higher organization level such as a pathway, cellular compart-
ment, or protein complex. We used GO bioinformatic tools to
test whether the brain and the SH-SY5Y neuroblastoma BLOC-
1-sensitive proteomes converge onto known and novel cellular
processes (Fig. 4). We sought to prioritize statistically the onto-
logical categories for hypothesis formulation and testing (Fig. 1).
We investigated whether GO terms associated just with the pro-
teome identified in SH-SY5Y neuroblastoma cells would be any
different from the ontology terms derived from the mouse sensi-
tive proteome and the BLOC-1-sensitive proteome, which en-
compasses both the SH-SY5Y neuroblastoma and mouse brain
proteomes. We used the GeneTerm Linker tool, which relies on
fuzzy linkage between genes and ontology terms to identify their
Figure1. Experimental design to obtain and prioritize the BLOC-1-sensitive proteome. Shown is the experimentalwork flow to
determine the BLOC-1-sensitive proteome using quantitativemass spectrometry to compare the proteomes of wild-type and null
dysbindin brains (Bloc1s8 sdy/sdy) by TMT as well as neuroblastoma cells control and rendered deficient in BLOC-1 by shRNA using
SILAC.
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Figure2. Componentsof theBLOC-1-sensitiveproteome.A–A2, Significant TMTproteomehits fromwild-type (Bloc1s8/) anddysbindin-null newbornbrains (Bloc1s8 sdy/sdy).A, Volcanoplot
of all TMT protein quantitations. Hits significantly modified by the Bloc1s8 sdy/sdy are depicted by red-lined circles. A1 and A2 present a hierarchical clustering of the mouse genotypes and changes
in protein expression for all significant hits and show upregulated and downregulated proteins, respectively. Each column corresponds to an individual animal. Columns and rows were analyzed
using Kendall’s tau distance algorithm according to GENE-E (Broad Institute, MIT). B to B2 present significant SILAC proteome hits from neuroblastoma cells expressing control shRNA and shRNAs
directed either to Bloc1s5 muted or Bloc-1s6 pallidin. B, Volcano plots of all SILAC protein quantitations in Bloc1s5 muted or Bloc-1s6 pallidin downregulated cells. Hits significantly modified by
BLOC-1 complex subunits downregulation are depicted by red-lined circles. B1 and B2 depict heat maps of proteins upregulated and downregulated by shRNA. Columns present from left to right:
fold change, whether a protein was quantified in Bloc1s5–6 shRNA-treated cells, and the number of independent SILAC experiments in which the protein was quantitated.
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convergence and associations (Fontanillo et al., 2011). The hu-
man neuroblastoma proteome identified 15 cellular component
ontology termmetagroups, whereas the mouse proteome identi-
fied 13 metagroups (Fig. 4A, gray and teal symbols, respectively).
Nine of the ontological metagroups were shared between the
mouse brain and neuroblastoma proteomes (Fig. 4A, red font),
indicating that these proteomes do not differ in their GO archi-
tecture (p 0.151, two-tailed Fisher’s exact probability test).
The five most significant terms within the human sensitive
proteome were in order of significance: cytoplasmic membrane-
bounded vesicle (GO: 0016023), melanosome (GO: 0042470),
neuron projection (GO: 0043005), lysosome (GO: 0005764), and
actin cytoskeleton (GO: 0015629). The reliability of this algo-
rithm was determined by the identification of ontology terms
defining organelles and cellular compartments in which function
or markers are perturbed by BLOC-1 deficiencies. These subcel-
lular compartments include melanosomes, platelet granules,
synapse, late endosomes, and lysosomes. The addition of the
Bloc1s8 sdy/sdy brain proteome to the neuroblastoma proteome
increased the number of ontological termmetagroups to 23 (Fig.
4A, blue symbols). Importantly, the top cellular component on-
tology terms of the BLOC-1-sensitive proteomewere shared with
those of the mouse brain and neuroblastoma proteome consid-
ered in isolation except in their statistical prioritization. In fact,
the BLOC-1-sensitive proteome identified the actin cytoskeleton
(GO: 0015629; GO: 0043202) as the top ontology term (p 
1012, hypergeometric test; Fig. 4A, blue symbols).
We probed the robustness of the BLOC-1-sensitive proteome
ontology using two different bioinformatic tools, DAVID and
ENRICHR (Fig. 4B–D). These tools differ from GeneTerm
Linker in their data-processing algorithms (Huang Da et al.,
2009; Chen et al., 2013). DAVID identifiedmost GO terms found
with GeneTerm Linker either using cellular component or bio-
logical process ontology categories (Fig. 4B,C). Among overlap-
ping terms, cytoskeleton (GO: 0005856) and actin cytoskeleton
(GO: 0015629) were significantly represented (p 106 and p
0.0018, respectively. Fisher’s exact test). Similarly, ENRICHR
scored actin binding (GO: 0003779) and SNARE binding (GO:
0000149) as top molecular functions predicted from the BLOC-
1-sensitive proteome (combined scores 12, log p-value Fisher’s
exact test  z-score; Fig. 4D). We and others have tested the
functional association of the SNARE fusion machinery and the
BLOC-1 complex (Ghiani et al., 2010; Dickman et al., 2012;
Gokhale et al., 2015b). Therefore, these statistically prioritized
ontological categories identify known pathways and/or subcellu-
lar compartments in which the BLOC-1 complex resides or is
Figure3. TheBLOC-1-sensitive proteomeenriches geneproducts associatedwithpsychiatric disorders andexpressed in developinghumanbrain.A, Shown is the analysis of theBLOC-1-sensitive
proteome using the GDA algorithm to identify molecular connections between gene sets and diseases Park et al., 2014; http://gda.cs.tufts.edu/. p-values were calculated using 10,000 permu-
tations. Significant hits are depicted with shades of blue. N depicts the number of gene products from the BLOC-1-sensitive proteome in the MeSH category. B, BLOC-1-sensitive proteome
(mouse human), Bloc1s8 sdy/sdy-sensitive proteome (mouse), and Bloc1s5–6 shRNA-sensitive proteomes were subjected to expression analysis across brain regions and development using the
CSEA algorithm http://genetics.wustl.edu/jdlab/csea-tool-2/; Dougherty et al., 2010. Columns and rows represent Fisher’s exact p-values corrected by Benjamini–Hochberg. Datawere analyzed
by hierarchical clustering using Pearson’s correlation according to GENE-E. Significant values are depicted in blue.
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required. Ontology strongly argues that the actin cytoskeleton
and the BLOC-1 complex belong to a common molecular
pathway.
To test whether the actin cytoskeleton and the BLOC-1 com-
plex converge on a shared pathway, we selectedmolecular targets
among the 29 proteins belonging to the actin-binding ontology
term (GO: 0003779; Fig. 4D). We determined previously that the
WASH complex and annexin A2 (ANXA2) interact with the
BLOC-1 complex to regulate the actin cytoskeleton at endosomes
(Ryder et al., 2013; Delevoye et al., 2016). We found downregu-
lated ANXA2 within the BLOC-1-sensitive proteome (Fig. 2B2).
Annexin A2 and the WASH complex activate the Arp2/3 actin
Figure 4. GO analyses of the BLOC-1-sensitive proteome. A, BLOC-1-sensitive proteome (mouse human, blue symbols), Bloc1s5–6 shRNA-sensitive proteomes (human, gray symbols), and
the Bloc1s8 sdy/sdy-sensitive proteome (mouse, teal symbols) were analyzed using the GeneTerm Linker tool (Fontanillo et al., 2011). Nine ontology terms common tomouse and human proteomes
are in red font.BandCdepict the cellular componentandbiological processGO terms for theBLOC-1-sensitiveproteomeusing theDAVID tool, respectively (HuangDaet al., 2009). Circledareadepicts
number of gene products from the BLOC-1-sensitive proteome present in the term. Circle color depicts corrected p-values, lines and their thickness depict GO termswith the number of shared gene
products. D and E illustrate GO analysis and the CORUM protein complex analysis of the BLOC-1-sensitive proteome according to ENRICH [combined score (log p-value Fisher’s exact test)
(z-score); Chen et al., 2013].
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polymerization complex, suggesting that the Arp2/3 complex could
be a downstream BLOC-1 pathway component. We used the
ENRICHR tool to prioritize statistically complexes curated in the
CORUMdatabaseofproteincomplexes (Fig. 4E;Rueppet al., 2010).
The top ranked predicted complex was Arp2/3 represented by four
of its seven subunits (ACTR3,ARPC1A,ARPC2,ARPC5; combined
score  2.64). These four Arp2/3 subunits were putatively down-
regulated in the BLOC-1-sensitive proteome (Fig. 2B2). The SWAP
and the BLOC-1 complexes closely scored with the Arp2/3 complex
(combined scores2.5). The SWAP complex was implicated in
B-cell-specific Iggenerecombination,yetoneof its subunits, SWAP-
70, bindsdirectly to actin andacts as a guanine-nucleotide-exchange
factor required for actin-dependent membrane ruffling (Borggrefe
et al., 1998; Shinohara et al., 2002; Ihara et al., 2006).
Arp2/3 complex expression is reduced in BLOC-1 deficiency
We confirmed the effects of BLOC-1 loss of function on the
expression of Arp2/3 complex subunits in diverse cells and
hippocampal fractions enriched in synapses, also called synapto-
somes (Fig. 5). We used antibodies against the Arp2/3 subunits
Arpc2 and Arpc5 to measure Arp2/3 complex levels and con-
trasted these results with VAMP7, a protein with expression that
is reduced in BLOC-1 deficiencies (Salazar et al., 2006; Newell-
Litwa et al., 2010). Arpc2 and Arpc5 expression was consistently
downregulated in all cells regardless of whether BLOC-1 was
downregulatedwith shRNAs against Bloc1s5, 6 or 8 in neuroblas-
toma cells (Fig. 5A–C1). Similarly, the shRNA against Bloc1s6
reduced Arpc2 and 5 expression regardless of whether the
shRNA-treated cells were SH-SY5Y neuroblastoma (Fig. 5A–C1)
orMNT-1melanoma cells (Fig. 5D–D1).Wemeasured the levels
of Arpc2 and 5 in immortalized melanocytes isolated from mice
carrying null mutations of Bloc1s5 and 6, Bloc1s5mu/mu, and
Bloc1s6pa / pa (Fig. 5E–E1). Arpc2 and 5 expression was increased
by rescuing thesemutants cells with cDNAs encoding themissing
subunits (Fig. 5E, cf. even and odd lanes). These results demon-
strate that reduced levels of BLOC-1 complex decrease the ex-
pression levels of Arp2/3 subunits in diverse cell lines.
We assessedwhetherArp2/3 complex subunits expressionwas
affected in adult dysbindin-null Bloc1s8 sdy/sdy mouse hippocam-
pus and synaptic enriched fractions. Arpc2 and Arcp5 expression
was not altered in total brain or hippocampal homogenates from
adult Bloc1s8 sdy/sdy mice (Fig. 5F, lanes 1 and 4, F1). However,
Arpc5 expression was reduced by 50% in synaptosomes from
Bloc1s8 sdy/sdy hippocampus. The synaptic vesiclemarker SV2was
used to determine the extent of synaptic enrichment in synapto-
some fractions (Fig. 5F,G). In contrast with Arpc5, Arpc2 levels
were not affected by the Bloc1s8 sdy/sdy allele compared with wild-
type synaptosomes and a loading control, Hsp90 (Fig. 5F, lanes 3
and 6, G, cf. even and odd lanes and G1). These results indicate
that expression of selected subunits of the Arp2/3 complex is
decreased in synaptic enriched fractions of adult dysbindin-null
hippocampus. Collectively, these results show that the integrity
of the BLOC-1 complex is required tomaintain the expression of
subunits of the Arp2/3 complex. Furthermore, our results con-
firm that GO distillation of the BLOC-1-sensitive proteome reli-
ably and robustly identifies a molecular pathway converging on
BLOC-1.
The WASH complex is an Arp2/3 activator that resides in
endosomes and interacts with the BLOC-1 complex (Seaman et
al., 2013; Ryder et al., 2013). We measured the levels of BLOC-1,
Arp2/3 complex subunits, and ataxin 2 to determine whether the
BLOC-1 complex was the most upstream component on a path-
Figure 5. The Arp2/3 actin polymerization complex is downregulated after BLOC-1 loss-of-function. A–C, SH-SY5Y cells were treated with control or shRNAs against either one of three BLOC-1
subunits (Bloc1s5, 6, and 8) and cell extracts analyzed by immunoblotwith antibodies against the BLOC-1-sensitive proteome components: Arp2/3 complex subunits (Arpc2 and 5), ataxin 2 (Atxn2),
and plexin A2 (PlxnA2). Antibodies against actin, BLOC-1 subunits, and the BLOC-1-sensitive SNARE VAMP7 were used as controls. D, MNT1 melanoma cells were treated with control or Bloc1s6
shRNAs and cell extracts analyzed as in A. E, Immortalized melanocytes frommouse mutants carrying null mutations in the BLOC-1 subunits Bloc1s5–6 (Bloc1s5mu / mu and Bloc1s6 pa / pa) or cells
rescued by expression of themissing subunit were analyzed as inA. F,G, Synaptosomes of six wild-type and six Bloc1s8 sdy/sdy hippocampi were analyzed. F,G, Three independent fractionations. In
F, all fractions are depicted (H, homogenate and P1, low speed pellet), whereas in G, only synaptosomes are shown. Samples were probed by immunoblot with Arpc2 and 5 antibodies, hsp90 as
loading control, dysbindin, and the synaptic vesicle marker SV to indicate synapse enrichment. A1–G1, Dot plots representing the protein expression normalized to the control genotype. Each dot
depicts an independent determination from at least three independent experiments. Red line marks 100%. All quantitations in A1 to E1were significantly different from actin. In F1 and G1, only
Arpc5 was significantly different compared with controls with hsp90 (F, G). Significance was determined by Kruskal–Wallis test followed by Wilcoxon Mann–Whitney nonparametric tests.
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way interacting with the Arp2/3 complex
via the WASH complex. We used control
mouse fibroblasts in which the Wash1
gene was engineered as a flox conditional
allele (WASH f / f) and null cells in which
Wash1 was excised with cre recombinase
(WASH /; Gomez et al., 2012). We
confirmed the excision of theWash1 gene
measuring the expression of two subunits
of the WASH complex, strumpellin and
FAM21, the expression of which was re-
duced by 50% (Fig. 6; Gomez et al.,
2012). Moreover, and similar to what we
observed in BLOC-1-deficient cells and
synaptosomes, the expression of the
Arp2/3 subunit Arpc5 and ataxin were
significantly downregulated and upregu-
lated, respectively (Fig. 6). These changes
in two BLOC-1-sensitive proteins oc-
curred even though the BLOC-1 complex
was unaffected in WASH-null cells, as
measured by the expression of the
BLOC-1 subunits Bloc1s6 (pallidin) and
Bloc1s8 (dysbindin) (Fig. 6). These results
support a model in which the BLOC-1,
WASH, and Arp2/3 complexes are orga-
nized sequentially on a pathway. We fur-
ther tested a pathwaymodel to investigate
whether BLOC-1, WASH, and Arp2/3
complexes could coprecipitate. We found
previously that BLOC-1 andWASH com-
plexes coimmunoprecipitate with antibodies against recombinant
FLAG-tagged dysbindin expressed in SH-SY5Yneuroblastoma cells
(Ryder et al., 2013). FLAG-tagged dysbindin precipitated the
BLOC-1 complex subunit Bloc1s6 pallidin, alongwith theWASH
subunits strumpellin and FAM21 and the Arp2/3 subunit Arpc2
(Fig. 6D, lane 1). Importantly, reverse immunoprecipitations
with antibodies against Arpc2 brought down the BLOC-1 com-
plex subunit Bloc1s6 pallidin (Fig. 6E, lane 1). In these experi-
ments, we excluded spurious binding of BLOC-1, WASH, and
Arp2/3 subunits to bead–antibody complexes with either addi-
tion of an excess FLAG peptide to immunoprecipitates (Fig. 6D,
lane 2) or using beads decorated with an anti-HA antibody (Fig.
6E, lane 2). Further probing of Arpc2 immunoprecipitates with
antibodies against strumpellin and FAM21 was precluded be-
cause all antibodies are raised in the same species. We conclude
that BLOC-1 and Arp2/3 form complexes that include Arp2/3
activators such as the WASH complex establishing a sequentially
organized pathway.
Arp2/3 and BLOC-1 complexes interact
Our hypothesis that the Arp2/3 complex and BLOC-1 participate
in a common pathway makes three testable predictions that we
focused on. First, the dynamic of actin filaments should be im-
paired in compartments in which the BLOC-1 complex normally
resides. Second, genetic deficiencies in BLOC-1 should pheno-
copy mutations in subunits of the Arp2/3 complex. Finally, tran-
sheterozygotic mutations either between two distinct BLOC-1
subunits or one BLOC-1 and Arp2/3 subunits should generate
similar phenotypic outcomes.
We measured actin dynamics using fluorescent recovery after
photobleaching (FRAP) of the F-actin probes Lifeact-RFP and
actin-GFP expressed in the same cells (Fig. 7; Riedl et al., 2008).
We expressed these probes in cells carrying an exofacially FLAG
tagged -adrenergic receptor in which endocytosis is induced by
the agonist isoproterenol. Isoproterenol-induced receptor inter-
nalization allowed us to define precisely early endosomes func-
tionally (Fig. 7C). The dynamics of endosome localized actin
filaments was similarly reported by Lifeact-RFP and actin-GFP
(Fig. 7A). Moreover, both probes experienced negligible bleach-
ing due to imaging (Fig. 7B). Therefore, we focused on Lifeact-
GFP because actin-GFP is partially functional (Doyle and
Botstein, 1996; Deibler et al., 2011).We demonstrated previously
that the size and tubulation of -adrenergic receptor-positive
endosomes is increased by BLOC-1 downregulation (Puthenv-
eedu et al., 2010; Ryder et al., 2013). We transduced cells
with control and Bloc1s6 shRNA lentiviruses to downregulate
BLOC-1 complexes. LifeAct labeled discrete actin-positive do-
mains in the limiting membrane of early endosomes, which were
identified by the presence of FLAG antibodies internalized after
10 min of isoproterenol addition (Fig. 7C). These actin spots
rapidly recovered their LifeAct FRAP in control cells (Fig. 7D,E).
In contrast, FRAP was significantly reduced in BLOC-1-
downregulated cells compared with control shRNA-treated cells
(Fig. 7D,E). These results demonstrate that actin dynamics at
early endosomes is decreased in cells in which the function of the
BLOC-1 is impaired.
Drosophila Arp2/3 and BLOC-1 complexes
interact genetically
We tested our hypothesis that the Arp2/3 complex and BLOC-1
participate in a common pathway with a genetic analysis of the
Drosophila third-instar larva neuromuscular junction (NMJ)
(Fig. 8) andDrosophilaDA neurons focusing on the morpholog-
ically distinct Class-IV (C-IV) DA neurons. We chose the NMJ
Figure 6. Genetic and biochemical interactions of the BLOC-1,WASH, and Arp2/3 complexes.A, Control (WASH f / f) andWASH-
null (WASH /) mouse embryonic fibroblast cell extracts were analyzed by immunoblot with antibodies against the BLOC-1-
sensitive proteome components Arp2/3 complex subunits (Arpc2 and 5) and ataxin 2 (Atxn2), as well as antibodies against actin,
BLOC-1 subunits (Bloc1s6 and 8), and the WASH complex subunits strumpellin and FAM21. B, Dot plots representing the protein
expressionnormalized to the control genotype. Eachdot represents an independent determination fromthreeor four independent
experiments. Red linemarks 100%. p-values were obtained by comparing against actin using the Kruskal–Wallis test followed by
WilcoxonMann–Whitney nonparametric tests. Arpc2 and BLOC-1 subunits were not significant (NS). Asterisksmark all significant
values ( p 0.0017). D, E, Immunoprecipitations of FLAG-tagged dysbindin expressed in SH-SY5Y cells (D) or immunoprecipita-
tions with Arpc2 antibodies (E). BLOC-1 complex was detected by immunoblot of the precipitated complexes with antibodies
against FLAG or pallidin, WASH complexes were revealed by blotting with antibodies against strumpellin and FAM21; the Arp2/3
complex was detected with antibodies against Arpc2 (D, E, n 3).
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synapse because it doubles its synaptic bouton numbers in
BLOC-1 loss-of-function mutations (Mullin et al., 2015). We
selected the C-IV DA neurons because their dendritic arbor is
sensitive to genetic disruption of actin cytoskeleton components
and their terminal branches are enriched in actin (Andersen et al.,
2005; Jinushi-Nakao et al., 2007; Iyer et al., 2012; Ferreira et al.,
2014). We focused on mutants in the orthologs of mammalian
Bloc1s1, 6, and 8, which are encoded by the Drosophila genes
blos1, pldn, and dysb. The products of these Drosophila genes
assemble into a bonafide BLOC-1 complex (Cheli et al., 2010;
Mullin et al., 2015). We first resolved a discrepancy of reported
bouton count phenotypes in BLOC-1 mutants (Dickman and
Davis, 2009;Mullin et al., 2015) and tested whether food compo-
sition is a source of these differences.We raised our stocks on our
food and the food used by Dickman and Davis (2009), herein
referred to as DD food (Fig. 8A,C). The DD food caused an
increase in the number of boutons in wild-type w1118 flies that
was identical to the number of boutons observed in all BLOC-1
mutant animals regardless of the food on which they were grown
(Fig. 8B,D,E). The low bouton count observed in our wild-type
w1118 animals raised on our food was also observed in two addi-
tional w1118 independent stocks of wild-type flies, c155 animals
and the w1118 animals used in Dickman and Davis (2009), thus
excluding genotypic differences in our stocks (Fig. 8B and data
not shown). Importantly, the dysb1 increased bouton count phe-
notype could be rescued by the expression of a UAS-Dysb-Venus
transgene driven by the c155 neuronal GAL4 driver (Fig. 8B,D).
We used this robust bouton count morphological assay to
test whether Drosophila BLOC-1 and Arp2/3 mutant alleles phe-
nocopy each other. Homozygous mutant blos1 ex65, pldn, and
dysb1 animals significantly increased their synaptic bouton
counts compared with control w1118 animals (Fig. 8B,D,E). The
increased bouton phenotype observed in blos1 ex65 and dysb1mu-
tants alleles is equally severe in heterozygous and homozygous
animals (Fig. 8B,D,E; Mullin et al., 2013). As predicted, the in-
creased synaptic bouton phenotype was also evident in two lethal
alleles of the Drosophila Arp2/3 subunit Arpc1 when introduced
as heterozygous mutations, Arpc1Q25st/ and Arpc1Q25sd/ (Fig.
8B,E; Hudson andCooley, 2002). These results demonstrate that
mutations in BLOC-1 complex and Arp2/3 subunits phenocopy
each other at the neuromuscular synapse, suggesting they con-
verge on a common mechanism.
The synaptic bouton phenotype of blos1heterozygous animals
is suppressed when combined with other loss-of-function alleles
of another BLOC-1 subunit (Mullin et al., 2013). This observa-
tion offers a powerful assay to test whether BLOC-1 and Arp2/3
Figure 7. Filamentous actin dynamics are reduced in endosomes of BLOC-1-downregulated cells. HEK293 cells expressing the -adrenergic receptor tagged with exofacial FLAG tag were
transfected with LifeAct-RFP and Actin-GFP and the receptor was induced to internalize with isoproterenol for 10 min. Receptor internalization was followed with fluorescently labeled FLAG
antibodies. A, FRAP of LifeAct-RFP and Actin-GFP localized to early endosomes identified by internalized receptors tagged with FLAG antibodies (endosomes not shown). B, Presents bleaching of
both probes due to imaging. C–E, Control scramble (gray symbols, E) and Bloc1s6 shRNA-treated HEK293 cells expressing LifeAct-GFP and a N-terminal FLAG tagged-adrenergic receptor (teal
symbols, E) were imaged after inducing early endosome labelingwith fluorescent FLAG antibodies (SSF-B2) and isoproterenol for 10min.D, E, Endosome LifeAct-GFP signalwas bleached and FRAP
measured as described. E, p-values were obtained by comparing scrambled and Bloc1s6 shRNA-treated cells at specific time points after photobleaching using the Kruskal–Wallis test followed by
Wilcoxon Mann–Whitney nonparametric tests. Numbers under symbols depict the number of endosomes quantified per condition and collected in three independent experiments.
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complexes converge on a pathway. Transheterozygotic animals
carrying one copy of blos1 ex65 and either one of the Arpc1 alleles
indeed suppressed the phenotype observed in each one of these
deficiencies in isolation (Fig. 8B,E). The same suppression of the
bouton phenotype was observed in transheterozygotic animals
carrying one copy of pldn or dysb1 in combination with
Arpc1Q25sd/ (Fig. 8B,E). All transheterozygotic synaptic bouton
counts were similar to wild-type w1118 flies and were also signif-
icantly different from each one of the mutant alleles in isolation
(Fig. 8B,E). We observed no differences in the size of the target
muscle by a 50% reduction in Arpc1 dosage (data not shown), an
observation consistent with the reported lack of effect of Arp2/3
either in assembly of actin filaments or contraction in differenti-
ated striated muscle (Pollard et al., 2002). These results indicate
that the BLOC-1 andArp2/3 complexes converge on a pathway to
regulate synapse morphology.
We tested whether genetic interactions between BLOC-1 and
Arp2/3 complexes were similar in dendrites and NMJ terminals.
Therefore, we studied theDrosophila third-instar larvae C-IVDA
neurons. These neurons possess an elaborate and stereotypic
dendritic arbor with a complexity that is sensitive to genetic per-
turbation of actin modulators (Andersen et al., 2005; Jinushi-
Nakao et al., 2007; Iyer et al., 2012; Ferreira et al., 2014). We
investigated whether hemideficiencies in Arpc1 and the BLOC-1
subunits blos1 and dysb could alter the dendritic arborization of
these neurons. Mutant blos1 and dysb decreased the number of
dendrite branches and the total dendrite length per neuron (Fig.
9A,C,D). These blos1 and dysb mutant phenotypes were more
pronounced in the actin-rich terminal branches, as demonstrated
by the reversed Strahler analysis, in which branches of the 1 and 2
categories (i.e., terminals) were the most affected (Fig. 9E).
Branches closer to the cell body were not significantly affected in
these BLOC-1 hemideficiencies (Fig. 9E; Strahler categories 3–8).
In contrast, the dendritic arbor was not affected in Arpc1Q25sd/
C-IV DA neurons (Fig. 9A,C–E). With respect to genetic inter-
actions between BLOC-1 and Arp2/3 complexes in C-IV den-
drites, haploinsufficiency dendritic phenotypes observed in
blos1 ex65 were further enhanced by the transheterozygotic
Arpc1Q25sd allele in the case of the total number of branches (Fig.
9A,C); however, the haploinsufficiency phenotypes observed in
dysb1 were not modified by the transheterozygotic Arpc1Q25sd
allele (Fig. 9A,C–E). We confirmed that the C-IV DA neurons’
dendritic arbor indeed cell autonomously requires the Arp2/3
complex by creatingArpc1Q25sd homozygous-null mutant clones
in sensory neurons using MARCM (Fig. 9B,F). Arpc1Q25sd mu-
tant C-IV MARCM clones exhibited drastically decreased
complexity of the dendritic tree, indicating that the Arp2/3 com-
plex is necessary for normal dendritic development of sensory
neurons (Fig. 9B,F). These results demonstrate that BLOC-1 and
Arp2/3 complexes are required for dendritic development by
mechanisms that differ between presynaptic and dendritic
compartments.
Arp2/3 and BLOC-1 modulate presynaptic plasticity
Mutations in dysb block a philanthotoxin-induced homeostatic in-
crease in quantal content that maintains muscle response during
evoked potentials. This adaptive synaptic response is localized to the
presynaptic compartment (Dickman and Davis, 2009; Dickman et
Figure 8. The Drosophila BLOC-1 and Arp2/3 complexes genetically interact in the synapse. A, B, Drosophila third-instar larva NMJs were stained with HRP antibodies to label nerve terminals in
wild-type (A, B; w 1118; D, three different stocks of w 1118 or c 155), BLOC-1-deficient animals (B–E; pldn /, dysb 1, blos1 ex65), two null alleles in the Arp2/3 complex (B–E, Arpc1 Q25st/ and
Arpc1 Q25sd/), and transheterozygotes of the BLOC-1 subunits alleles and one of two Arpc1 alleles. A, Images of synapses of animals raised in our food ( symbol in C) and DD food (Dickman and
Davis, 2009) with bouton counts in C. C–E, Bouton counts are presented as box plots where the box indicates percentiles 25th and 75th. Box line represents sample median and diamonds sample
mean, notches mark the half-width. Numbers of animals per genotype are in the abscissa in italics. Comparisons were made by the Kruskal–Wallis test followed by Wilcoxon Mann–Whitney
nonparametric tests.
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Figure 9. The Drosophila BLOC-1 and Arp2/3 complexes affect dendritic morphology in C-IV DA neurons. A, Representative live confocal images of C-IV DA neurons of the specified genotypes
labeled by ppk-EGFP. B, Control and Arpc1-null C-IV neurons generated by MARCM (Arpc1 /). Scale bars in A and B correspond to 100m. C and D show quantitative analysis of total number
of dendritic branches and total dendritic length in the specified genotypes. Data are presented as box plotswhere the box indicates percentiles 25th and75th. Box line represents samplemedian and
diamonds samplemean, notches mark the half-width. E and F depict reversed Strahler branch analysis that shows that BLOC-1 haploinsifficiency phenotypes significantly affect terminal actin rich
branches (Strahler number 1 and 2). Comparisonsweremade by the Kruskal–Wallis test followed byWilcoxonMann–Whitney nonparametric tests. Numbers of animals per genotype in C–F are in
the abscissa in italics in D.
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al., 2012; Gokhale et al., 2015b). We used
this dysb sensitive phenotype to determine
whether an interaction between Dysbindin
and the Arp2/3 complex could modulate
presynapticmechanisms.As reportedprevi-
ously, exposure to philanthotoxin did not
affect evoked potentials (EJP) after 10 min
of toxin addition inwild-typew1118 animals
(Fig. 10A). In contrast, the EJP amplitude
was decreased in the dysb1 flies after toxin
addition, a reflection of decreased quantal
content compared withw1118 (Fig. 10A,C).
As described previously, single alleles of
dysb1 or blos1ex65 didnot affect the response
to philanthotoxin (Fig. 10C; Dickman and
Davis, 2009; Dickman et al., 2012; Gokhale
et al., 2015b). Single-copy loss of arpc1
(Arpc1Q25sd/) phenocopied the dysb1 im-
paired response after toxin addition (Fig.
10A,C). We tested whether this arpc1-
dependent phenotype was presynaptic by
analyzing transheterozygotic animals har-
boring one copy of blos1 ex65 or dysb1 in
combination with Arpc1Q25sd/. Simple
copy loss of these two BLOC-1 subunits re-
verted the decreased Arpc1Q25sd/ plasticity
phenotype to levels close to wild-typew1118
(Fig. 10A,C). None of these effects was due
to differences in the response of synapses to
philanthotoxin. All animals decreased the
amplitude of spontaneous fusion events
(mEJP) by 50% after toxin addition (Fig.
10B). These results demonstrate that sub-
units of the BLOC-1 complex interact with
components of the Arp2/3 complex to
modulate an adaptive synaptic response.
Collectively, our findings demonstrate that
ontologies derived from proteomes sensi-
tive to single genedefects inform the formu-
lation of novel schizophrenia mechanistic
hypotheses converging at the synapse.
Discussion
We used global quantitative proteome profiling and GO to identify
and prioritize unbiasedly pathways altered by defect in single genes
implicated in neurodevelopmental disorders. We used this strategy
in neuronal cells and in tissue with reduced expression of one of
three BLOC-1 subunits: Bloc1s5 (muted), Bloc1s6 (pallidin), and
Bloc1s8 (dysbindin). Our goal was to identify effectors downstream
of the BLOC-1 complex and proteins belonging to compensatory
mechanisms activated by BLOC-1 genetic defects. The neuronal
BLOC-1-sensitive proteome satisfies three criteria. First, the pro-
teome sensitive to BLOC-1 deficiencies enriches gene products and
ontological terms implicated in psychosis and schizophrenia risk
(Fig. 3). Second, the proteome is modularly organized into discrete
GO categories. These ontology categories include known and novel
pathways sensitive to BLOC-1 genetic defects (Fig. 4). Finally, prior-
itizationof theproteomebyGObrought into focus theArp2/3 com-
plex, which we demonstrate interacts genetically with the BLOC-1
complex at aDrosophilamodel synapse, the larval NMJ (Fig. 8).
Whole-brain Bloc1s8-null proteome poorly overlapped with
the proteome of neuroblastoma cells downregulated for BLOC-1
subunits likely because of a low discovery rate of isolated pro-
teomes. However, the ontological organization of the human or
mouse brain proteomes did not differ statistically. In fact, the
addition of the brain proteome to the proteome of the BLOC-1
downregulated human neuroblastoma cells, the BLOC-1-
sensitive proteome, improved the significance of common GO
terms identified by the mouse brain and human neuroblastoma
considered in isolation. We distilled the BLOC-1-sensitive pro-
teome into two statistically prioritized GO terms, actin cytoskel-
eton (GO: 0015629) and actin binding (GO: 0003779). Among
the actin binding proteins in GO: 0003779 (Fig. 4D), the protein
content of which has been reported to be reduced in dysbindin-
BLOC-1-null cells or brain. These include the Arp2/3 activator
annexin A2 (ANXA2), synapsin 1 (SYN1), and a subunit of
calcium/calmodulin-dependent protein kinase II (CAMK2B;
Numakawa et al., 2004; Morel et al., 2009; Fei et al., 2010; Borge-
sius et al., 2011; Papaleo et al., 2012; Saggu et al., 2013; Jia et al.,
2014; Delevoye et al., 2016).We identified a newmolecular target
sensitive to dysbindin-BLOC-1 defects within the actin cytoskel-
eton ontology terms, the Arp2/3 complex (Pollard, 2007; Rotty et
al., 2013; Spence and Soderling, 2015). This actin regulatory com-
plex was represented by four of seven subunits among our mass
spectrometry candidate hits (ACTR3, ARPC1A, ARPC2, and
ARPC5). Of these four subunits, we found reduced expression
Figure10. Drosophiladysbindin andArp2/3 complexes interact tomodulate homeostatic synaptic plasticity.A, Representative
EJP and mEJP traces without philanthotoxin-433 (PhTx, black) and after PhTx incubation (blue). B, mEJP amplitude after
philanthotoxin-433 addition (average and SEM). C, Quantal content across different genotypes. Data are presented as box plots
where the box indicates percentiles 25th and 75th. Box line represents samplemedian and diamonds samplemean, notchesmark
the half-width. Numbers of animals per genotype are in the abscissa. Comparisonsweremade by the Kruskal–Wallis test followed
by Wilcoxon Mann–Whitney nonparametric tests.
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of ARPC1A, ARPC2, and ACTR3 in Bloc1s5 and 6 shRNA-
downregulated cells and confirmed these mass spectrometry re-
sults measuring ARPC2 and ARPC5 expression in cells in which
BLOC-1 expression was impaired by shRNA or genomic defects.
Reduced expression of Arp2/3 complex in BLOC-1 defects has
functional consequences, as determined by decreased actin dy-
namics in early endosomes and suppression of BLOC-1 subunit
morphological and plasticity mutant phenotypes by hemidefi-
ciencies of Arpc1, a subunit of the Drosophila Arp2/3 complex.
This BLOC-1 and Arp2/3 pathway is further supported by bio-
chemical interactions of BLOC-1 and Arp2/3 complexes (Fig. 6).
Presently, we do not knowwhether Arp2/3 directly interacts with
BLOC-1 or whether BLOC-1 associates with the Arp2/3 complex
via either one of three Arp2/3 activators that bind BLOC-1 com-
plex subunits: the WASH complex, WAVE2, or annexin A2 (Ito
et al., 2010; Ryder et al., 2013; Delevoye et al., 2016). However,
regardless of how BLOC-1, Arp2/3, and an Arp2/3 activator in-
teract, we postulate that BLOC-1 acts upstream of the WASH
complex, WAVE2, or annexin A2 to modulate Arp2/3 activity
and direct Arp2/3 subcellular localization (Delevoye et al., 2016).
In turn, active Arp2/3 would participate in a BLOC-1-actin-
dependent endosome sorting event into vesicles or tubules (Ito et
al., 2010; Ryder et al., 2013; Delevoye et al., 2016). We favor this
model because it explains the following observations presented
here and in previous work. First, WASH or annexin A2 down-
regulation, as well as pharmacological inhibition of Arp2/3, dis-
rupt tubule-dependent BLOC-1 cargo sorting (Ryder et al., 2013;
Delevoye et al., 2016). Second, a sequential organization of the
BLOC-1, WASH, and Arp2/3 complexes explains that the
BLOC-1 complex is unaltered in cells lacking theWASHcomplex
(Fig. 6; Ryder et al., 2013), whereas Arp2/3 subunit expression is
reduced in both BLOC-1 andWASH complexmutations (Figs. 5,
6; Ryder et al., 2013). Third, a BLOC-1-activating role upstream
of Arp2/3 accounts for the decreased actin dynamics in early
endosomes in BLOC-1-deficient cells (Fig. 7). Fourth, sequential
organization model of BLOC-1, WASH, and Arp2/3 complexes
accounts for the similarity between BLOC-1 and Arp2/3 mutant
phenotypes at Drosophila synapses. Finally, this model explains
the suppression of a synaptic bouton number phenotype in
BLOC-1-null alleles by Arp2/3 mutations. At first glance, the
suppression of the BLOC-1 bouton phenotype by Arp2/3 alleles
could be interpreted as BLOC-1 and Arp2/3 having opposing
effects on actin polymerization. However, we do not favor this
interpretation because the Drosophila synaptic bouton pheno-
type is a dominant phenotype, which is suppressed by double
heterozygotic mutations in two distinct BLOC-1 subunits (Mul-
lin et al., 2015). We interpreted this suppression of the BLOC-1
synaptic phenotype by another BLOC-1 subunit mutant as the
removal of BLOC-1 remnants complex with dominant effect
(Mullin et al., 2015). Therefore, Arp2/3 deficiencies would
suppress a dominant BLOC-1 phenotype, suggesting that the
function of BLOC-1 is activating and upstream of the Arp2/3
complex.
Dysbindin, other BLOC-1 subunits, andArp2/3 complex sub-
units localize to presynaptic and postsynaptic compartments in
neuronal cells (Talbot et al., 2006; Larimore et al., 2013). Dysbin-
din and BLOC-1 function are presynaptically required for synap-
tic vesicle protein delivery to and recycling within the nerve
terminal and homeostatic synaptic plasticity (Dickman and Da-
vis, 2009; Newell-Litwa et al., 2009; Newell-Litwa et al., 2010;
Larimore et al., 2011; Dickman et al., 2012; Di Giovanni and
Sheng, 2015; Gokhale et al., 2015b; Mullin et al., 2015). Postsyn-
aptically, dysbindin andArp2/3 complex subunits are required to
modulate spine dynamics, actin polymerization, and neurotrans-
mitter receptor surface expression or total content (Iizuka et al.,
2007; Shao et al., 2011; Kim et al., 2013; Rocca et al., 2013; Jia et
al., 2014).We usedDrosophila larvae neurons to address whether
presynaptic and dendritic compartments are similarly sensitive
to BLOC-1 and Arp2/3 genetic defects. Presynaptic terminals
were affected by single-copy loss of either BLOC-1 subunits or
Arp2/3 subunits (Figs. 8, 10). However, dendrites were only sen-
sitive to BLOC-1 hemideficiencies, not to a single-copy loss of
Arpc1 (Fig. 9). We postulate two nonexclusive models to explain
these results. First, the abundance of Arp2/3 complexes could be
limiting in Drosophila presynaptic compartments, but not in
dendrites, amodel drawn from the relative distribution of Arp2/3
complexes in mammalian synapses. Arp2/3 levels are higher in
spines compared with axon terminals in mammalian neurons
(Ra´cz andWeinberg, 2008; Korobova and Svitkina, 2010; Spence
et al., 2016). A second model considers that Arp2/3 likely inter-
acts with multiple upstream modulators in dendritic compart-
ments, whereas BLOC-1 may be a chief upstream interactor of
Arp2/3 complexes in presynaptic terminals. Either model, or
combinations of thereof, could account for the lack of effect of a
single-copy loss ofArpc1 in dendritic morphology and the differ-
ent way by which BLOC-1 and Arp2/3 interact genetically in
transheterozygotic analysis in dendrites compared with presyn-
aptic terminals.
Regardless of which one of these models accounts for our
observations, both likely converge on a BLOC-1-actin pathway
organizing actin-rich domains in organelles. Actin-rich domains
in endosomes or synaptic vesicles could participate in protein
sorting via endosome tubules or vesicles or to propel vesicles
within the synapse (Qualmann et al., 2000). Our finding that
DrosophilaBLOC-1 orArp2/3 complex hemideficiencies alter the
morphology of the Drosophila neuromuscular synapse suggest
the intriguing possibility that receptors required for maintaining
synapse morphology may be sorted from endosomes by BLOC-
1-Arp2/3-dependent mechanisms. For example, enhanced
TGF- signaling is sufficient to cause overgrowth of the NMJ,
suggesting that disruption of endosome sorting, thus preventing
receptor activity downregulation, may contribute to increased
synaptic bouton phenotypes (Aberle et al., 2002; Marque´s et al.,
2002; Harris and Littleton, 2015). This is the case of the late-
endosome-localized spinter, the mutation of which induces syn-
aptic overgrowth that requires the activity of the TGF- receptor
wit (Sweeney and Davis, 2002). If receptor signal transduction is
increased in BLOC-1 and Arp2/3 mutant alleles, then synaptic
bouton overgrowth should be suppressed in mutants of signal
transduction pathways controlling DrosophilaNMJ morphology
(Aberle et al., 2002; Marque´s et al., 2002; Harris and Littleton,
2015). Similarly, in mammalian cells, BLOC-1-Arp2/3-dep-
endent mechanisms could control the subcellular localization
and activity of other receptor signaling pathways. These include
dopamine receptors and NMDA and AMPA glutamatergic re-
ceptors, which have been shown previously to be sensitive to
BLOC-1 deficiency, as well as other receptors present in the
BLOC-1-sensitive proteome such as PLXA2, NRCAM, and cell
adhesionmolecules (GO: 0005178; Iizuka et al., 2007;Marley and
von Zastrow, 2010; Karlsgodt et al., 2011; Shao et al., 2011; Saggu
et al., 2013; Orozco et al., 2014).
The unbiased identification of a proteome sensitive to a
monogenic defect provides insight into predicting genotype-
associated pathways and phenotypes. At a minimum, the BLOC-
1-sensitive proteome identifies organelles and subcellular domains
in which biogenesis and/or constituents are affected by BLOC-1
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deficiencies. The BLOC-1-sensitive proteome predicts effects of
BLOC-1 genetic defects on neuronal and non-neuronal organ-
elles. For example, defective melanosome and platelet granule
biogenesis characterize BLOC-1 mutations in vertebrates
(Raposo and Marks, 2007; Dell’Angelica, 2009; Ghiani and
Dell’Angelica, 2011;Wei and Li, 2013). These defective organelles
are represented in the GO terms describing pigmentation (GO:
0048753 and GO: 0043473) and platelet granule organization
(GO: 0060155) inferred from the BLOC-1-sensitive proteome.
Similarly, known functions of the BLOC-1 complex such as in-
teractions with the SNARE membrane fusion machinery or as a
factor required for the morphology/composition of presynaptic
and postsynaptic domains are encompassed by the SNARE or
syntaxin binding (GO: 0000149 and 0017075) and neuron pro-
jection morphogenesis (GO: 0048812) ontological categories
(Ghiani et al., 2010; Larimore et al., 2011;Dickman et al., 2012; Jia
et al., 2014; Di Giovanni and Sheng, 2015; Gokhale et al., 2015b).
Our data indicate that the phenotype predictive value of the
BLOC-1-sensitive proteome expands to neurodevelopmental
disorders such as schizophrenia. The genetic association of poly-
morphisms in the gene encoding dysbindin (DTNBP1) with
schizophrenia is disputed (Farrell et al., 2015). However, down-
regulation of dysbindin expression in brains from schizophrenia
patients is a strong argument for dysbindin as a part of the pro-
cesses associated with disease (Talbot et al., 2004; Tang et al.,
2009; Talbot et al., 2011). The BLOC-1-sensitive proteome pro-
vides additional insight into the association of dysbindin with
schizophrenia because it significantly enriches genes products
associated with psychotic disorders as determined with the GDA
algorithm (Park et al., 2014). For example, GDA finds 11 gene
products in common with the Psychotic Disorders category
(F03.700.675) and 31 gene products with the Schizophrenia and
Disorders with Psychotic Features category (F03.700; Park et al.,
2014). This latter category includesmolecules such as the scaffold
SHANK1, plexin A2, the enzyme dopamine  hydroxylase. We
demonstrated previously that dopamine  hydroxylase copre-
cipitates with the BLOC-1 complex and the expression of this
enzyme is sensitive to BLOC-1 deficiency (Gokhale et al., 2015a).
Second, GO analysis of schizophrenia candidate genes identified
from genomic or schizophrenia brain gene expression studies
overlap with ontology terms inferred from the BLOC-1-sensitive
proteome (Gilman et al., 2012; Fromer et al., 2014; Purcell et al.,
2014; Fo¨cking et al., 2015; Zhao et al., 2015; Pers et al., 2016). This
overlap includes GO terms encompassing actin dynamics, stabil-
ity, and actin-dependent membrane specializations (Fromer et
al., 2014; Zhao et al., 2015). The involvement of actin cytoskeletal
components in neurodevelopmental disorders is not just limited
to ontologies inferred from candidate genes. In fact, Arp2/3 com-
plex subunitmessenger RNAs are reduced in specific layers of the
prefrontal cortex of schizophrenia patients (Datta et al., 2016).
Moreover, genetic disruption of the neuronal mouse Arp2/3
complex causes schizophrenia endophenotypes (Kim et al.,
2015). Genes causative of neurodevelopmental disorders reside
upstream of modulators of actin polymerization. Well studied
examples are DISC1, which binds kalirin, a protein that activates
Rac1 and p21-activated kinase (Hayashi-Takagi et al., 2010; Pen-
zes and Remmers, 2012). SHANK3, a protein that interacts di-
rectly with Arp2/3 and the upregulation of which increases
filamentous actin in spines (Han et al., 2013). Finally, FMRP
binds to CYFIP1 a molecule that regulates the activity of the
WAVE1 complex, an Arp2/3 activator, thus establishing amolec-
ular mechanism linking translational control and actin polymeriza-
tion (Abekhoukh and Bardoni, 2014; Pathania et al., 2014; Yoon et
al., 2014). Because dysbindin binds toWAVE2, WAVE-CYFIP-like
components in the BLOC-1-sensitive proteome may serve as a
platform linking translational control and actin cytoskeleton dy-
namics. Ourwork adds significantly to the proposition that Arp2/3-
dependent actin polymerization at presynaptic and postsynaptic
compartments is a major neurodevelopmental disorder risk path-
way. Our results indicate that ontologically prioritized proteomics
can offer mechanistic insight intomonogenic and polygenic neuro-
developmental disorder pathogenesis, disorder-specific endophe-
notypes, and genetic modifiers of disease.
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